Animal models of idiosyncratic drug-induced liver injury—Current status
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
The infrequent occurrence of idiosyncratic reactions and their dependence on individual sensitivity factors allow them to go undetected in current preclinical safety evaluation using conventional animal tests. Better predictive models for idiosyncratic, drug-induced liver injury (IDILI) would enable the preclinical elimination of drug candidates with idiosyncrasy liability and could provide evidence for a mode of action for these responses, suggest early biomarkers of IDILI, and lead to the development of mechanism-based, in vitro screens. Desirable characteristics of an animal model include the production of liver injury in a large fraction of animals of relatively inexpensive species/strains and the ability to distinguish drugs that cause IDILI in humans from ones that do not. The mechanistic basis for idiosyncratic reactions remains poorly understood. However, attempts at animal model development have been made based on several hypothesized modes of action of IDILI. These hypotheses have centered on drug disposition polymorphisms, adaptive immunity, mitochondrial dysfunction, failure to adapt to modest injury, inflammatory stress, and multiple determinants, and the success in achieving animal models of liver injury for each of these is discussed. Despite numerous challenges associated with animal models of IDILI, some models have emerged and are proving useful in exploring potential mechanisms. Current animal models are not perfect, but they hold promise for increasing the prediction and understanding of human idiosyncratic drug reactions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammatory mechanisms in ischemic stroke: role of inflammatory cells
Jin, R., Yang, G., & Li, G. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.1109766 · Cited by 1,521
Idiosyncratic drug hepatotoxicity
Kaplowitz, N. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1750 · Cited by 1,054
McKenzie, R., Fried, M. W., Sallie, R., Conjeevaram, H., Di Bisceglie, A. M., Park, Y., Savarese, B., Kleiner, D., Tsokos, M., Luciano, C., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510263331702 · Cited by 616 · cited 1×
“…of mitochondrial swelling and destruction of cristae, all findings similar to those reported in human fialuridine toxicity (Lewis et al�, 1997; Kleiner et al�, 1997; McKenzie et al�, 1995; Stevenson et al�, 1995)� In other studies in both woodchucks and dogs, fialuridine treatment led to a…”
ResultFattinger, K. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.114667 · Cited by 509
Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity
Boelsterli, U. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(03)00368-5 · Cited by 403
Daly, A. K., Aithal, G. P., Leathart, J. B. S., Swainsbury, R. A., Dang, T. S., & Day, C. P. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.11.023 · Cited by 348 · cited 2×
“…their ability to bind to cellular proteins and thereby initiate events that somehow lead to hepatocellular necrosis� Indeed, polymorphisms in UDP-glucuronyl transferase 2B7 have been reported as a risk factor for diclofenac IDILI in humans (Daly et al�, 2007)� Unlike most other drugs that…”
BackgroundLabbe, G., Pessayre, D., & Fromenty, B. (2008) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2008.00608.x · Cited by 317 · cited 1×
“…screening arsenal for preclinical detection of hepatotoxic drug candidates and their elimination early in the drug development process (Xu et al�, 2008; Labbe et al�, 2008)� Despite evidence from studies in vitro demonstrating that numerous drugs associated with IDILI can affect…”
BackgroundCASE REPORT: Troglitazone-Induced Fulminant Hepatic Failure
Murphy, E. J., Davern, T. J., Shakil, A. O., Shick, L., Masharani, U., Chow, H., Freise, C., Lee, W. M., & Bass, N. M. (2000) · Digestive Diseases and Sciences · doi:10.1023/a:1005405526283 · Cited by 111
Fialuridine accumulates in DNA of dogs, monkeys, and rats following long-term oral administration
Richardson, F. C., Engelhardt, J. A., & Bowsher, R. R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12003 · Cited by 58 · cited 1×
“…1994)� However, dogs, mice, and rats did not respond to the drug with overt liver injury, despite having comparable or greater incorporation of fialuridine into mitochondrial DNA (Richardson et al�, 1994, 1999)� The woodchuck hepatitis virus model was originally developed as a surrogate for…”
BackgroundShaw, P. J., Beggs, K. M., Sparkenbaugh, E. M., Dugan, C. M., Ganey, P. E., & Roth, R. A. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp163 · Cited by 41
Self-citation
Cited by
Models of Drug Induced Liver Injury (DILI)—Current Issues and Future Perspectives
Kuna, L., Bozic, I., Kizivat, T., Bojanic, K., Mrso, M., Kralj, E., Smolic, R., Wu, G. Y., & Smolic, M. (2018) · Current Drug Metabolism · doi:10.2174/1389200219666180523095355 · Cited by 127
Gustafsson, F., Foster, A. J., Sarda, S., Bridgland-Taylor, M. H., & Kenna, J. G. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kft223 · Cited by 77
Tu, C., Niu, M., Wei, A.-W., Tang, J.-F., Zhang, L., Jing, J., Xiao, X.-H., & Wang, J.-B. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s299892 · Cited by 15
Kenna, J. G. (2017) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1290082 · Cited by 7
Metadata
- Authors
- Roth, R. A., & Ganey, P. E.
- Venue
- Critical Reviews in Toxicology
- Publisher
- Informa UK Limited
- Published
- 2011-07-04
- Volume
- 41
- Issue
- 9
- Pages
- 723-739
- ISSN
- 0045-6446 (ISSN-L)
- 1040-8444
- 1547-6898
- OpenAlex
- W2029818729
- Cited by
- 80
- References
- 10
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Animal models of idiosyncratic drug-induced liver injury—Current status. https://app.cochat.ai/papers/10.3109/10408444.2011.575765
- The paper
- Roth, R. A., & Ganey, P. E. (2011). Animal models of idiosyncratic drug-induced liver injury—Current status. Critical Reviews in Toxicology. https://doi.org/10.3109/10408444.2011.575765
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.